The Prostate Biopsy market is a subset of the larger Surgical Procedures market. It involves the removal of tissue samples from the prostate gland for diagnostic purposes. The procedure is typically performed using a transrectal ultrasound-guided biopsy, which is a minimally invasive procedure. The biopsy is used to diagnose prostate cancer, as well as other conditions such as prostatitis and benign prostatic hyperplasia. The Prostate Biopsy market is highly competitive, with a variety of companies offering products and services. These include medical device manufacturers, such as Olympus, Stryker, and Cook Medical, as well as biopsy services providers, such as Urovant Sciences and UroGen Pharma. Additionally, there are a number of healthcare providers that offer prostate biopsy services, such as hospitals, clinics, and private practices. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
